Skip to content
Avertix Medical logo — First and only FDA-Approved Implantable Cardiac Surveillance...

Avertix Medical

First and only FDA-Approved Implantable Cardiac Surveillance System | A New Day Dawns for Heart Attack Survivors and ACD

Founded 2001 57 employees Debt Financing Total: $13.48M Health Care, Medical Devices

General Information

Company Name Avertix Medical
Founded Year 2001
Employees 57
Industries Health Care, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Avertix Medical. To contact Avertix Medical, visit avertix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Avertix Medical compare?

A PDF of Avertix Medical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Avertix Medical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Avertix Medical

Avertix Medical is a pioneering company in the Health Care and Medical Devices industries. Their FDA-approved Guardian System offers an innovative approach to managing Advanced Cardiovascular Disease. The system is designed to alert patients to seek medical attention for Acute Coronary Syndrome, including silent heart attacks, addressing the issue of delayed treatment contributing to high mortality and morbidity rates. With less than 20% of patients presenting to the emergency room actually experiencing a true positive ACS event, and more than one-third of heart attacks having atypical or no symptoms, Avertix’s Guardian System aims to fill a crucial gap in patient care. Founded in 2001, Avertix recently secured a significant $13.48M in Debt Financing investment on 13 November 2023, showcasing investor confidence in the company's mission to advance patient care standards.

Business keywords: Cardiovascular Disease, Implantable Technology, Patient Care, FDA Approval, Acute Coronary Syndrome, Heart Attack, Healthcare Innovation, Cardiac Surveillance, Patient Alert System

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $13.48M -
13 Nov 2023

Avertix Medical Alternatives & Competitors

View All Alternatives
Avertix Medical vs
iMEDRIX INC.
iMEDRIX INC. United States

MOBILE - CONNECTED CARDIAC CARE. ANYTIME. ANYWHERE.

25 employees
Health Care, Medical Devices
Avertix Medical vs

Millions of ECGs are performed every week with technology that hasn't changed in 50 years. We intend...

Debt Financing
20 employees
AI, Health Care
Avertix Medical vs

Risiko für plötzlichen Herztod reduzieren!

237 employees
Health Care, Medical Devices

FAQ About Avertix Medical

First and only FDA-Approved Implantable Cardiac Surveillance System | A New Day Dawns for Heart Attack Survivors and ACD
Avertix Medical was founded in 2001.
Avertix Medical operates in Health Care and Medical Devices. Its work centres on Cardiovascular Disease, Implantable Technology, Patient Care and FDA Approval.
Avertix Medical has approximately 57 employees.
Avertix Medical has completed 1 funding round, raising a total of $13.48M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Avertix Medical include iMEDRIX INC., HeartSciences (NASDAQ:HSCS), ZOLL CMS GmbH, FineHeart, NimbleHeart. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avertix Medical and iMEDRIX INC. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Avertix Medical, https://bouncewatch.com/company/avertix-medical, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout